MFIM
GSK icon

Mesirow Financial Investment Management’s GSK GSK Stock Holding History

Mesirow Financial Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$896K Buy
17,087
+13
+0.1% +$688 0.01% 287
2026
Q1 		$942K Buy
17,074
+2,252
+15% +$122K 0.02% 274
2025
Q4 		$727K Sell
14,822
-1,715
-10% -$80K 0.01% 281
2025
Q3 		$714K Sell
16,537
-89
-0.5% -$3.48K 0.01% 311
2025
Q2 		$638K Sell
16,626
-88
-0.5% -$3.36K 0.01% 322
2025
Q1 		$647K Sell
16,714
-16,692
-50% -$611K 0.01% 317
2024
Q4 		$1.13M Buy
33,406
+16,713
+100% +$602K 0.02% 249
2024
Q3 		$682K Buy
16,693
+323
+2% +$13.2K 0.01% 319
2024
Q2 		$630K Sell
16,370
-293
-2% -$12.3K 0.01% 303
2024
Q1 		$714K Buy
16,663
+459
+3% +$18.9K 0.02% 297
2023
Q4 		$601K Buy
+16,204
New +$582K 0.02% 285

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mesirow Financial Investment Management's GSK Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its GSK (GSK) stake by 0.08% in Q2 2026, buying an estimated $688 and bringing the position to 17,087 shares worth $896K. The position accounts for 0.01% of the portfolio, ranked #287.

Mesirow Financial Investment Management first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.13M in Q4 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Mesirow Financial Investment Management held 17,087 shares of GSK worth $896K as of Q2 2026.
  • Mesirow Financial Investment Management bought 13 GSK shares in Q2 2026, an estimated $688.
  • GSK made up 0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #287 holding.
  • Mesirow Financial Investment Management first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's GSK position peaked at $1.13M in Q4 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.